Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ActivaTek
West Valley City, Utah, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
ActivaTek develops and commercializes iontophoresis-based transdermal drug delivery systems (including Trivarion, ActivaPatch, and ActivaDose II) that are FDA 510(k)-cleared iontophoresis devices for clinical use in delivering anti-inflammatory drugs and local anesthetics through the skin; products are commercially marketed, primarily for physical medicine/rehabilitation and pain management.[2][3][6][8]
- Therapeutic areas
- ImmunologyNeurologyOther
- Modalities
- DeviceNon-pharmacological therapyNanoparticle
- Industry
- Therapeutic Medical Devices
Beyond the preview
Go deeper on ActivaTek.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ActivaTek.